文献速递前列腺癌

当代前列腺癌诊断时风险特征的国家趋势

Contemporary national trends in prostate cancer risk profile at diagnosis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2019-06-24

该研究利用美国国家癌症数据库分析2004至2014年755,567例活检确诊的临床局限型前列腺腺癌(T1-4N0M0)男性,评估诊断时风险分布的时间趋势。低风险比例从38.32%降至27.23%,中风险从40.49%升至46.72%,高风险从21.19%升至26.05%,转移性疾病从3251例(2.88%)增至6886例(7.19%)。结论认为中高风险和转移性前列腺癌比例大幅增加,低风险比例下降,主要由高级别疾病诊断增加驱动。

要点

  • 低风险前列腺癌比例从2004年38.32%降至2014年27.23%(p < 0.001)。
  • 中风险比例从40.49%升至46.72%,高风险从21.19%升至26.05%(p < 0.001)。
  • 转移性疾病例数从3251例(2.88%)增至6886例(7.19%)(p < 0.001)。

核心结论

  • 过去十年局限型中/高风险和转移性前列腺癌比例大幅增加,低风险比例下降,该转变主要由高级别疾病诊断增加驱动。
  • 国家指南反对PSA筛查可能促成了这些发现。

研究设计与样本

  • 利用美国国家癌症数据库识别2004至2014年活检确诊的临床局限型前列腺腺癌(T1-4N0M0)男性,共755,567例。
  • 评估美国国家综合癌症网络风险组及其子组件(PSA、Gleason评分、临床T分期)的比例分布时间趋势,并分析中/高风险及转移性疾病男性的子组件趋势。

主要发现

  • 低风险前列腺癌比例从38.32%降至27.23%(p < 0.001)。
  • 局限型中风险比例从40.49%升至46.72%(p < 0.001),高风险从21.19%升至26.05%(p < 0.001)。
  • 该变化主要由Gleason 7和Gleason 8-10癌症比例增加驱动。
  • 转移性疾病例数从2004年3251例(2.88%)持续增至2014年6886例(7.19%)(p < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over the past decade prostate cancer (PCa) diagnostic approaches have evolved away from aggressive prostate-specific antigen (PSA) screening. While a goal of these changes is to decrease over diagnosis and treatment, little is known about the downstream effects on PCa risk distribution at the time of diagnosis. To better understand these effects, we used a national cohort of men to investigate temporal trends in PCa risk profile at diagnosis. METHODS: Using the National Cancer Database, we identified men diagnosed with biopsy-confirmed clinically localized prostate adenocarcinoma (T1-4N0M0) from 2004 to 2014. We assessed temporal trends in proportional distribution of National Comprehensive Cancer Network risk groups as well as their sub-components (PSA, Gleason score, clinical T stage). We also evaluated trends in these sub-components among men with intermediate- and high-risk disease as well as those with metastatic disease. RESULTS: In our cohort of 755,567 men diagnosed between 2004 and 2014, there was a decrease in the proportion of men diagnosed with low-risk PCa (38.32 to 27.23%, p < 0.001) and a consequent increase in the proportion of localized intermediate-risk (40.49 to 46.72%, p < 0.001) and high-risk diagnoses (21.19 to 26.05%, p < 0.001). This was primarily driven by an increased proportion of Gleason 7 and Gleason 8-10 cancer, respectively. The number of men presenting with metastatic disease consistently increased from 3251 (2.88%) in 2004 to 6886 (7.19%) in 2014 (p < 0.001). CONCLUSIONS: The proportion of localized intermediate/high risk and metastatic PCa has substantially increased over the past decade, while the proportion of low-risk disease has decreased. This shift has been primarily driven by increased diagnosis of high-grade disease. National guidelines advising against PSA screening may have contributed to these findings.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Fletcher SA, von Landenberg N, Cole AP, et al. Contemporary national trends in prostate cancer risk profile at diagnosis. Prostate Cancer Prostatic Dis. 2019. PMID: 31235801. doi:10.1038/s41391-019-0157-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。